ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

IGC IGC Pharma Inc

0.48
0.05 (11.63%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
IGC Pharma Inc IGC AMEX 普通株式
  前日比 前日比 % 現在値 時刻
0.05 11.63% 0.48 08:51:12
始値 安値 高値 終値 前日終値
0.421 0.417551 0.496 0.458 0.43
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1620:00BWIGC-AD1’s Interim Phase 2 Data Show a Reduction in..
2024/4/0922:00BWIGC Pharma Adds Advisor in Artificial Intelligence
2024/3/2704:00BWIGC Pharma Announces $3 Million Unregistered Private..
2024/3/2100:00BWIGC Pharma Announces Positive Interim Results for IGC-AD1 in..
2024/3/2020:00BWIGC PHARMA Announces its Participation at the Benzinga..
2024/3/1304:00BWIGC Pharma (IGC): Healthcare Leader Terry Lierman Joins..
2024/2/2903:00BWPromising Results: TGR-63 Enhances Memory in Alzheimer's..
2024/2/2402:01BWIGC Pharma Announces Equity Analyst Coverage by Ascendiant..
2024/2/1709:05BWIGC Pharma Reports Third Quarter Fiscal 2024 Results
2024/2/1506:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/0123:20BWIGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's..
2024/2/0106:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/2323:20BWIGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63..
2024/1/1723:20BWIGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing..
2024/1/0914:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/3006:54EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/1923:20BWPatent Granted to IGC Pharma for Groundbreaking Drug..
2023/12/1323:30BWIGC Pharma Announces Participation in Biotech Showcase and..
2023/12/0622:30BWIGC Pharma Announces Collaboration to Integrate AI into..
2023/11/2122:30BWIGC Pharma Announces Master Agreement with Leading South..
2023/11/1322:00BWIGC Pharma Reports Second Quarter Fiscal 2024 Results
2023/11/1007:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/2806:21EDGAR2Form 8-K - Current report
2023/10/2805:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/2004:30BWIGC Pharma Granted European Patent for Groundbreaking..
2023/9/3006:23EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/2203:30BWIGC Announces Results of its 2023 Annual Stockholders..
2023/8/2201:44EDGAR2Form 8-K - Current report
2023/8/1421:30BWIGC Pharma Reports First Quarter Results; Company Continues..
2023/8/1105:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0221:30BWIGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the..
2023/7/2706:26EDGAR2Form DEF 14A - Other definitive proxy statements
2023/7/1818:22BWIGC Pharma, Inc. Presenting 6 Posters on the Positive Impact..
2023/7/1221:44BWIGC Reports Financial Results for Fiscal Year Ended March..
2023/7/0805:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/7/0800:41EDGAR2Form 8-K - Current report
2023/7/0722:15BWIGC Pharma Secures $12 Million Line of Credit from O-Bank..
2023/7/0620:46BWIGC Pharma Announces a $3 Million Private Placement of its..
2023/7/0105:03EDGAR2Form NT 10-K - Notification of inability to timely file Form..
2023/6/2910:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2902:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/0622:20BWIGC Pharma Receives Notice of Allowance for Patent on..
2023/6/0521:30BWIGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63..

最近閲覧した銘柄

Delayed Upgrade Clock